European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes.
Breast centre
Certification
Multidisciplinary
Quality control
Quality indicators
Journal
Breast care (Basel, Switzerland)
ISSN: 1661-3791
Titre abrégé: Breast Care (Basel)
Pays: Switzerland
ID NLM: 101254060
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
05
08
2019
accepted:
22
09
2019
entrez:
15
1
2020
pubmed:
15
1
2020
medline:
15
1
2020
Statut:
ppublish
Résumé
EUSOMA undertook the commitment of defining the requirements for a specialist breast centre, which has become the reference document for the implementation of breast centres. The EUSOMA requirements for a specialist breast centre give clear indications regarding the requisite caseload, dedicated team composition (core and non-core team), organisation, availability of services and equipment throughout the patient pathway, quality control, and application of a multidisciplinary approach. The minimum number of cases is 150 newly diagnosed breast cancer cases per year. Based on the EUSOMA requirements, a voluntary and accredited certification scheme has been developed. In Europe, other voluntary certification schemes are available, such as those developed by the German Cancer Society and German Society for Breast Disease, the National Cancer Peer Review Programme in the UK, and the "label de qualité" established by the Swiss Anticancer League and the Swiss Senology Society. The European Commission Initiative on Breast Cancer (ECIBC) has overseen the development of a European Quality Assurance Scheme. Nearly 20 years after the initial publication of the EUSOMA requirements, ensuring that all breast cancer patients in Europe are treated only in certified breast centres should be considered a high priority and eventually achieved through collaborative efforts.
Sections du résumé
BACKGROUND
BACKGROUND
EUSOMA undertook the commitment of defining the requirements for a specialist breast centre, which has become the reference document for the implementation of breast centres.
SUMMARY
CONCLUSIONS
The EUSOMA requirements for a specialist breast centre give clear indications regarding the requisite caseload, dedicated team composition (core and non-core team), organisation, availability of services and equipment throughout the patient pathway, quality control, and application of a multidisciplinary approach. The minimum number of cases is 150 newly diagnosed breast cancer cases per year. Based on the EUSOMA requirements, a voluntary and accredited certification scheme has been developed. In Europe, other voluntary certification schemes are available, such as those developed by the German Cancer Society and German Society for Breast Disease, the National Cancer Peer Review Programme in the UK, and the "label de qualité" established by the Swiss Anticancer League and the Swiss Senology Society. The European Commission Initiative on Breast Cancer (ECIBC) has overseen the development of a European Quality Assurance Scheme.
KEY MESSAGES
CONCLUSIONS
Nearly 20 years after the initial publication of the EUSOMA requirements, ensuring that all breast cancer patients in Europe are treated only in certified breast centres should be considered a high priority and eventually achieved through collaborative efforts.
Identifiants
pubmed: 31933581
doi: 10.1159/000503603
pii: brc-0014-0359
pmc: PMC6940462
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
359-365Informations de copyright
Copyright © 2019 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors have no conflicts of interest to declare.
Références
Ann Surg. 2018 Feb;267(2):375-381
pubmed: 27893532
Eur J Cancer. 2017 Nov;85:15-22
pubmed: 28881247
Eur J Cancer. 1999 Jan;35(1):14-5
pubmed: 10211082
Eur J Cancer. 2017 Nov;86:59-81
pubmed: 28963914
BMJ. 2012 Apr 26;344:e2718
pubmed: 22539013
Cureus. 2016 Nov 24;8(11):e895
pubmed: 28018765
Eur J Cancer. 2013 Nov;49(17):3579-87
pubmed: 23968730
Eur J Cancer. 2015 Jul;51(10):1221-30
pubmed: 25892645
Eur J Surg Oncol. 2015 Aug;41(8):1005-12
pubmed: 25986853
Eur J Cancer. 2000 Dec;36(18):2288-93
pubmed: 11094301
Am J Public Health. 1998 Mar;88(3):454-7
pubmed: 9518982